MF
ALDR

Manchester Financial’s Alder Biopharmaceuticals ALDR Stock Holding History

Manchester Financial’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,000
Closed -$24K – 507
2019
Q2 		$24K Buy
+2,000
New +$24.2K 0.01% 230

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manchester Financial's ALDR Position: Q3 2019 in Review

Manchester Financial sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 6,935 shares — an estimated $82K sold.

Manchester Financial first reported a position in ALDR in Q2 2019 and held it in 1 quarter. The position peaked at $82K in Q2 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Manchester Financial reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Manchester Financial sold 6,935 Alder Biopharmaceuticals shares in Q3 2019, an estimated $82K.
  • Manchester Financial first reported a position in Alder Biopharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Manchester Financial's Alder Biopharmaceuticals position peaked at $82K in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Manchester Financial's 13F filing for Q3 2019, filed 9 Oct 2019.